학술논문
Driving-related behaviors, attitudes, and perceptions among Australian medical cannabis users: results from the CAMS 20 survey.
Document Type
Academic Journal
Author
Arkell TR; Centre for Mental Health and Brain Science, Swinburne University of Technology, Melbourne, VIC, Australia. tarkell@swin.edu.au.; Abelev SV; Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.; Mills L; Drug and Alcohol Services, South East Sydney Local Health District, Sydney, NSW, Australia.; Department of Addiction Medicine, Faculty Medicine and Health, University of Sydney, Sydney, NSW, Australia.; Suraev A; Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.; Faculty of Science, School of Psychology, University of Sydney, Sydney, NSW, Australia.; Arnold JC; Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.; Discipline of Pharmacology, Sydney Pharmacy School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.; Lintzeris N; Drug and Alcohol Services, South East Sydney Local Health District, Sydney, NSW, Australia.; Department of Addiction Medicine, Faculty Medicine and Health, University of Sydney, Sydney, NSW, Australia.; McGregor IS; Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.; Faculty of Science, School of Psychology, University of Sydney, Sydney, NSW, Australia.
Source
Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101752723 Publication Model: Electronic Cited Medium: Internet ISSN: 2522-5782 (Electronic) Linking ISSN: 25225782 NLM ISO Abbreviation: J Cannabis Res Subsets: PubMed not MEDLINE
Subject
Language
English
Abstract
Road safety is an important concern amidst expanding worldwide access to legal cannabis. The present study reports on the driving-related subsection of the Cannabis as Medicine Survey 2020 (CAMS-20) which surveyed driving-related behaviors, attitudes, and perceptions among Australian medical cannabis (MC) users. Of the 1063 respondents who reported driving a motor vehicle in the past 12 months, 28% (297/1063) reported driving under the influence of cannabis (DUIC). Overall, 49-56% of respondents said they typically drive within 6 h of MC use, depending on the route of administration (oral or inhaled). Non-medical cannabis (NMC) was perceived to be more impairing for driving than MC. Binary logistic regression revealed associations between likelihood of DUIC and (1) inhaled routes of cannabis administration, (2) THC-dominant products, (3) illicit rather than prescribed use, (4) believing NMC does not impair driving, and (5) not being deterred by roadside drug testing. Overall, these findings suggest there is a relatively low perception of driving-related risk among MC users. Targeted education programs may be needed to highlight the potential risks associated with DUIC, and further research is needed to determine whether driving performance is differentially affected by MC and NMC.
(© 2023. Board of Governors of the Colorado State University System, acting by and through Colorado State University-Pueblo.)
(© 2023. Board of Governors of the Colorado State University System, acting by and through Colorado State University-Pueblo.)